Brought to you by 
REVA Medical completes its Australian IPO
27 Dec 2010
Executive Summary
US-based REVA Medical Inc. (bioresorbable stents) has completed its initial public offering on the Australian Securities Exchange. The company netted A$80.7mm ($80.4mm) through the sale of 7.7mm common shares (equal to 77.2 CHESS Depositary Interests) for A$11 each.
Deal Industry
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Site Specific
-
Drug Delivery
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
REVA Medical completes its Australian IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice